- Home
- CSTL vs PFLT Comparison
CSTL vs PFLT Comparison
Compare CSTL & PFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- PFLT
- Stock Information
- Founded
- CSTL 2007
- PFLT 2010
- Country
- CSTL United States
- PFLT United States
- Employees
- CSTL N/A
- PFLT N/A
- Industry
- CSTL Medical Specialities
- PFLT Finance: Consumer Services
- Sector
- CSTL Health Care
- PFLT Finance
- Exchange
- CSTL Nasdaq
- PFLT Nasdaq
- Market Cap
- CSTL 848.1M
- PFLT 885.6M
- IPO Year
- CSTL 2019
- PFLT N/A
- Fundamental
- Price
- CSTL $27.14
- PFLT $10.80
- Analyst Decision
- CSTL Strong Buy
- PFLT Strong Buy
- Analyst Count
- CSTL 6
- PFLT 2
- Target Price
- CSTL $39.67
- PFLT $12.00
- AVG Volume (30 Days)
- CSTL 301.1K
- PFLT 868.2K
- Earning Date
- CSTL 11-04-2024
- PFLT 02-05-2025
- Dividend Yield
- CSTL N/A
- PFLT 11.33%
- EPS Growth
- CSTL N/A
- PFLT 80.92
- EPS
- CSTL 0.21
- PFLT 1.40
- Revenue
- CSTL $311,878,000.00
- PFLT $186,355,000.00
- Revenue This Year
- CSTL $51.36
- PFLT $23.81
- Revenue Next Year
- CSTL N/A
- PFLT N/A
- P/E Ratio
- CSTL $131.77
- PFLT $7.77
- Revenue Growth
- CSTL 62.43
- PFLT 33.74
- 52 Week Low
- CSTL $16.97
- PFLT $10.28
- 52 Week High
- CSTL $35.84
- PFLT $12.63
- Technical
- Relative Strength Index (RSI)
- CSTL 39.78
- PFLT 41.01
- Support Level
- CSTL $26.99
- PFLT $10.56
- Resistance Level
- CSTL $28.08
- PFLT $10.86
- Average True Range (ATR)
- CSTL 1.51
- PFLT 0.13
- MACD
- CSTL -0.15
- PFLT -0.01
- Stochastic Oscillator
- CSTL 22.78
- PFLT 42.11
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
About PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.